Quetiapine 50 MG Oral Tablet — RxCUI 616487
RxNorm drug concept · Semantic clinical drug
RxCUI 616487
Semantic clinical drug · SCD
● Current RxNorm concept 170 FDA products
426 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI616487
Official nameQuetiapine 50 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asquetiapine (as quetiapine fumarate) 50 MG Oral Tablet; QUEtiapine fumarate 50 MG Oral Tablet
FDA products mapped170
Package NDCs mapped426
Reported Medicaid activity (SDUD)5,291,107 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Quetiapine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Quetiapine is approved to treat schizophrenia, bipolar disorder (both manic episodes and depressive episodes), and — in the extended-release form only — as an add-on to an antidepr...
- It depends on the form. If you're taking the regular tablet, you can take it with or without food — no restrictions. But if you're on the extended-release tablet, you should take i...
- Does it matter if I take quetiapine with food?
- Sleepiness is actually one of the most common side effects — in some studies, more than half of patients reported it. Quetiapine blocks histamine receptors in the brain, which has...
🕸️ Concept Web — How Quetiapine 50 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Quetiapine 50 MG Oral Tablet
RxCUI 616487 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Quetiapine
51272IN
-
Quetiapine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Seroquel
83553BN
-
Seroquel
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Quetiapine Oral Tablet
374646SCDF -
Quetiapine Oral Product
1157343SCDG -
Quetiapine Pill
1157344SCDG -
Quetiapine Oral Tablet [Seroquel]
368152SBDF -
Seroquel Oral Product
1180762SBDG -
Seroquel Pill
1180763SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Quetiapine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Quetiapine 50 MG
616486SCDC -
Quetiapine 50 MG Oral Tablet [Seroquel]
616489SBD -
Quetiapine 50 MG [Seroquel]
616488SBDC
-
Quetiapine 50 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Quetiapine 50 MG
SCDC · 616486 -
Quetiapine Oral Tablet
SCDF · 374646 -
Quetiapine Oral Product
SCDG · 1157343 -
Quetiapine Pill
SCDG · 1157344
Brand-Name Concepts
-
Quetiapine 50 MG Oral Tablet [Seroquel]
SBD · 616489 -
Quetiapine 50 MG [Seroquel]
SBDC · 616488 -
Quetiapine Oral Tablet [Seroquel]
SBDF · 368152 -
Seroquel Oral Product
SBDG · 1180762 -
Seroquel Pill
SBDG · 1180763 -
Seroquel
BN · 83553
📦 FDA Products & Package NDCs
170 products · 426 package NDCs
426 package NDCs map to RxCUI 616487 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65862-0493-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65862-493-01) | Quetiapine Fumarate | Aurobindo Pharma Limited | 2012-03-27 |
| 65862-0493-10 | 10 BLISTER PACK in 1 CARTON (65862-493-10) / 10 TABLET, FIL... | Quetiapine Fumarate | Aurobindo Pharma Limited | 2012-03-27 |
| 65862-0493-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (65862-493-99) | Quetiapine Fumarate | Aurobindo Pharma Limited | 2012-03-27 |
| 65862-0494-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65862-494-01) | Quetiapine Fumarate | Aurobindo Pharma Limited | 2012-03-27 |
| 65862-0494-10 | 10 BLISTER PACK in 1 CARTON (65862-494-10) / 10 TABLET, FIL... | Quetiapine Fumarate | Aurobindo Pharma Limited | 2012-03-27 |
| 65862-0494-60 | 60 TABLET, FILM COATED in 1 BOTTLE (65862-494-60) | Quetiapine Fumarate | Aurobindo Pharma Limited | 2012-03-27 |
| 65862-0494-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (65862-494-99) | Quetiapine Fumarate | Aurobindo Pharma Limited | 2012-03-27 |
| 65862-0495-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65862-495-01) | Quetiapine Fumarate | Aurobindo Pharma Limited | 2012-03-27 |
| 65862-0495-05 | 500 TABLET, FILM COATED in 1 BOTTLE (65862-495-05) | Quetiapine Fumarate | Aurobindo Pharma Limited | 2012-03-27 |
| 65862-0495-10 | 10 BLISTER PACK in 1 CARTON (65862-495-10) / 10 TABLET, FIL... | Quetiapine Fumarate | Aurobindo Pharma Limited | 2012-03-27 |
| 67046-1649-03 | 30 TABLET, FILM COATED in 1 BLISTER PACK (67046-1649-3) | Quetiapine Fumarate | Coupler LLC | 2026-01-15 |
| 67877-0242-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-242-01) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0242-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-242-10) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0242-33 | 1 BLISTER PACK in 1 CARTON (67877-242-33) / 10 TABLET, FILM... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0242-38 | 10 BLISTER PACK in 1 CARTON (67877-242-38) / 10 TABLET, FIL... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0245-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-245-01) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0245-33 | 1 BLISTER PACK in 1 CARTON (67877-245-33) / 10 TABLET, FILM... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0245-38 | 10 BLISTER PACK in 1 CARTON (67877-245-38) / 10 TABLET, FIL... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0246-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-246-01) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0246-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-246-10) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0246-33 | 1 BLISTER PACK in 1 CARTON (67877-246-33) / 10 TABLET, FILM... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0246-38 | 10 BLISTER PACK in 1 CARTON (67877-246-38) / 10 TABLET, FIL... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0247-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-247-10) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0247-33 | 1 BLISTER PACK in 1 CARTON (67877-247-33) / 10 TABLET, FILM... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0247-38 | 10 BLISTER PACK in 1 CARTON (67877-247-38) / 10 TABLET, FIL... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0247-60 | 60 TABLET, FILM COATED in 1 BOTTLE (67877-247-60) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0248-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-248-01) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0248-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-248-10) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0248-33 | 1 BLISTER PACK in 1 CARTON (67877-248-33) / 10 TABLET, FILM... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0248-38 | 10 BLISTER PACK in 1 CARTON (67877-248-38) / 10 TABLET, FIL... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0249-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-249-01) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0249-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-249-10) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0249-33 | 1 BLISTER PACK in 1 CARTON (67877-249-33) / 10 TABLET, FILM... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0249-38 | 10 BLISTER PACK in 1 CARTON (67877-249-38) / 10 TABLET, FIL... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0250-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-250-01) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0250-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-250-10) | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0250-33 | 1 BLISTER PACK in 1 CARTON (67877-250-33) / 10 TABLET, FILM... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 67877-0250-38 | 10 BLISTER PACK in 1 CARTON (67877-250-38) / 10 TABLET, FIL... | Quetiapine | Ascend Laboratories, LLC | 2013-03-01 |
| 68001-0180-00 | 100 TABLET in 1 BOTTLE (68001-180-00) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
| 68001-0180-08 | 1000 TABLET in 1 BOTTLE (68001-180-08) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
| 68001-0181-00 | 100 TABLET in 1 BOTTLE (68001-181-00) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
| 68001-0181-03 | 500 TABLET in 1 BOTTLE (68001-181-03) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
| 68001-0182-00 | 100 TABLET in 1 BOTTLE (68001-182-00) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
| 68001-0182-03 | 500 TABLET in 1 BOTTLE (68001-182-03) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
| 68001-0183-00 | 100 TABLET in 1 BOTTLE (68001-183-00) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
| 68001-0183-03 | 500 TABLET in 1 BOTTLE (68001-183-03) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
| 68001-0183-06 | 60 TABLET in 1 BOTTLE (68001-183-06) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
| 68001-0184-00 | 100 TABLET in 1 BOTTLE (68001-184-00) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
| 68001-0184-08 | 1000 TABLET in 1 BOTTLE (68001-184-08) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
| 68001-0185-00 | 100 TABLET in 1 BOTTLE (68001-185-00) | Quetiapine fumarate | BluePoint Laboratories | 2013-02-28 |
Observed labelers:
ASCLEMED USA INC. (42) ·
Bryant Ranch Prepack (30) ·
Ascend Laboratories, LLC (27) ·
Camber Pharmaceuticals, Inc. (25) ·
Alembic Pharmaceuticals Limited (24) ·
Aurobindo Pharma Limited (22)
· +29 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.